article Open AccessTop 1% cited
The prevalence of severe refractory asthma
Journal of Allergy and Clinical Immunology · 2014 · Vol. 135(4) · pp. 896–902
Pieter‐Paul Hekking✉(University of Amsterdam)Reinier Wener(University of Amsterdam)Marijke Amelink(University of Amsterdam)A. H. Zwinderman(University of Amsterdam)Marcel L. Bouvy(SIR Institute for Pharmacy Practice and Policy)Elisabeth H. Bel(University of Amsterdam)
Asthma and respiratory diseasesRespiratory and Cough-Related ResearchInhalation and Respiratory Drug DeliveryAsthmaMedicineMedical prescriptionRefractory (planetary science)ReimbursementPharmacyPopulationPediatricsInhalationIntensive care medicine
MeSH terms
Administration, InhalationAgedAsthmaFemaleHumansMaleMiddle AgedNetherlandsRisk FactorsSeverity of Illness IndexPrevalenceAnti-Asthmatic AgentsMedication Adherence
Funding
- GlaxoSmithKline
- Regeneron Pharmaceuticals
- Novartis Pharma
Citations
797
FWCI
12.85
field-weighted impact
References
26
Percentile
99%
vs. same field & year
Citations per year
References
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
European Respiratory Journal · 2013 · 3,864 citations
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
American Journal of Respiratory and Critical Care Medicine · 2009 · 2,105 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
